the lower incidence and severity of side effects in spite of similar or better effects recommend the combination of dextrothyroxin and beta-pyridylcarbinol for longterm therapy of moderate hypercholesterolemia .
C0011824
dextrothyroxin
C0020443
hypercholesterolemia